2 employees
Genometry commercializes a genome-wide, high-throughput, gene-expression profiling method for pharmaceutical discovery applications.
2012
$3M
from 1 investors over 1 rounds
Genometry, Inc raised $3M on September 21, 2012
Investors: Sands Capital Management